• Info
  • Insider Trading

John Harry Cross III - Insider Trading & Ownership

Location
C/O Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco, CA
Summary
The estimated net worth of John Harry Cross III is at least $1.11K dollars as of March 11, 2025. John Harry Cross III is the Chief Financial Officer of Sonnet BioTherapeutics Holdings, Inc. and owns shares of Sonnet BioTherapeutics Holdings, Inc. (SONN) stock worth about $1.11K.
Signature
/s/ Robert Cutler, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when John Harry Cross III files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John Harry Cross III

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SONN Sonnet BioTherapeutics Holdings, Inc. Chief Financial Officer $1.11K Dec 11, 2023
SNTI Senti Biosciences, Inc. Chief Financial Officer Mar 7, 2025

Insider Transactions Reported by John Harry Cross III:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.